In today’s recent session, 4.88 million shares of the Pfizer Inc (NYSE:PFE) have been traded, and its beta is 0.58. Most recently the company’s share price was $25.64, and it changed around -$0.23 or -0.89% from the last close, which brings the market valuation of the company to $145.30B. PFE at last check was trading at a discount to its 52-week high of $31.54, offering almost -23.01% off that amount. The share price’s 52-week low was $24.48, which indicates that the recent value has risen by an impressive 4.52% since then. We note from Pfizer Inc’s average daily trading volume that its 10-day average is 43.47 million shares, with the 3-month average coming to 43.24 million.
Pfizer Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.20. If we narrow it down even further, the data shows that 1 out of 24 analysts rate the stock as a Sell; another 3 rate it as Overweight. Among the rest, 13 recommended PFE as a Hold, whereas 7 deemed it a Buy, and 0 rated it as Underweight. Pfizer Inc is expected to report earnings per share of 0.71 for the current quarter.
Pfizer Inc (NYSE:PFE) trade information
Instantly PFE has been showing red trend so far today with a performance of -0.89% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 26.69 on recent trading dayincreased the stock’s daily price by 3.93%. The company’s shares are currently down -3.35% year-to-date, but still down -0.89% over the last five days. On the other hand, Pfizer Inc (NYSE:PFE) is -4.04% down in the 30-day period. We can see from the shorts that 91.78 million shares have been sold at a short interest cover period of 2.26 day(s).
The consensus price target as assigned by Wall Street analysts is $32, which translates to bulls needing to increase their stock price by 19.88% from its current value. Analyst projections state that PFE is forecast to be at a low of $32 and a high of $33.
Pfizer Inc (PFE) estimates and forecasts
The year-over-year growth rate is expected to be -0.99%, down from the previous year.
Consensus estimates provided by 12 financial analysts predict the company will bring in an average of 14.37B in revenue for the current quarter. 11 analysts expect Pfizer Inc to make 13.54B in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 14.88B and 13.28B respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -3.39%. Forecasts for the next quarter put sales growth at 1.93%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -13.25%. Pfizer Inc earnings are expected to increase by -5.45% in 2025, but the outlook is negative -0.89% per year for the next five years.
PFE Dividends
Pfizer Inc’s next quarterly earnings report is expected to be released in March. The annual dividend yield of the stock is 6.59 percent and its annual dividend per share was 1.69. It is important to note, however, that the 6.59% dividend yield ratio should be regarded as a guide only, as many other factors should be taken into consideration before making any investment decision. The average dividend yield for the past five years averaged 4.36 per year.
Pfizer Inc (NYSE:PFE)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.05% of Pfizer Inc shares, and 67.88% of them are in the hands of institutional investors. The stock currently has a share float of 67.91%. Pfizer Inc stock is held by 3599.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 9.0402% of the shares, which is about 511.4 million shares worth $14.31 billion.
BLACKROCK INC., with 7.5018% or 424.38 million shares worth $11.87 billion as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Vanguard 500 Index Fund were the top two Mutual Funds as of Sep 30, 2024 . The former held 179.55 shares worth $4.6 billion, making up 3.17% of all outstanding shares. On the other hand, Vanguard 500 Index Fund held roughly 148.41 shares worth around $3.8 billion, which represents about 2.62% of the total shares outstanding.
